How to Create a Drug Policy for Buyers That Ensures Compliance and Safety

Recent Trends in Workplace Drug Policies

In recent years, a growing number of organizations have revised their drug policies to address the unique risks faced by employees in procurement and supply chain roles. Buyers often have access to sensitive negotiations, controlled substances, or high-value transactions, making compliance a priority. The shift toward remote work has also raised questions about testing protocols and supervision.

Background: Why Buyers Require Specific Policies

Traditional drug policies often treat all employees uniformly. However, buyers in industries such as pharmaceuticals, chemicals, or logistics may handle regulated substances or work in environments where impairment poses direct safety hazards. The legal landscape varies by jurisdiction, with some states legalizing recreational or medical cannabis, complicating zero-tolerance approaches.

Key User Concerns

• Legal compliance: Policies must align with local, state, and federal laws regarding drug testing and privacy.
• Safety vs. privacy: Balancing the need for a drug-free workplace with employees' rights to lawful off-duty activities.
• Consistency: Ensuring that rules for buyers are applied fairly and not seen as discriminatory.
• Testing logistics: Determining when and how to test – pre-employment, random, post-incident, or for cause.
• Disciplinary measures: Clear consequences for violations while allowing for rehabilitation or accommodation.

Likely Impact of a Well-Designed Policy

A thorough policy can reduce accident risk, improve public trust, and limit liability. Buyers who feel their roles are understood are more likely to comply willingly. Conversely, overly broad or poorly communicated policies can lead to grievances, turnover, or legal challenges.

Organizations that adopt a risk-based approach—focusing on job duties rather than blanket testing—tend to see better outcomes. For example, policies that differentiate between safety-sensitive buyers and those in standard purchasing roles can reduce friction.

What to Watch Next

• Legislative changes: More states may move toward regulating drug testing of off-duty cannabis use, forcing policy updates.
• Technology in testing: Advances in oral fluid or hair testing could change reliability and turnaround times.
• Case law: Court decisions on reasonable suspicion and privacy rights will shape best practices.
• Industry benchmarks: Trade groups may issue model policies for procurement professionals.